Literature DB >> 16758

Effects of methionine-enkephalin on prolactin release and catecholamine levels and turnover in the median eminence.

L Ferland, K Fuxe, P Eneroth, J A Gustafsson, P Skett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 16758     DOI： 10.1016/0014-2999(77)90164-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  12 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 2.  Ontogenic studies of the neural control of adenohypophyseal hormones in the rat. II. Prolactin.

Authors:  D Becú-Villalobos; I M Lacau-Mengido; G S Díaz-Torga; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1992-02       Impact factor: 5.046

Review 3.  Comparative aspects of opioid-dopamine interaction.

Authors:  G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1982-09       Impact factor: 5.046

4.  Inhibition by naloxone of the rise in hypothalamic dopamine and serum prolactin induced by ethanol.

Authors:  A Seilicovich; M Rubio; B Duvilanski; V Muñoz Maines; V Rettori
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Inhibitory effects of centrally administered /ASU1-7/eel calcitonin on basal and stimulated prolactin release in rats.

Authors:  V Sibilia; C Netti; F Guidobono; I Villa; A Pecile
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

6.  Methysergide decreases prolactin release after FK 33-824 [Tyr-D-Ala-Gly-MePhe-Met(o)-ol], a potent analogue of methionine enkephalin. A study in man.

Authors:  G Jungkunz; N Nedopil; E Rüther
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  A possible role of endogenous opioids in the control of prolactin and luteinizing-hormone secretion in the human.

Authors:  J D Veldhuis; T J Worgul; R Monsaert; J M Hammond
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

8.  Variation in tolerance to the antinociceptive, hormonal and thermal effects of morphine after a 5-day pre-treatment of male rats with increasing doses of morphine.

Authors:  P T Männistö; S A Borisenko; P Rauhala; P Tuomainen; R K Tuominen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

9.  The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion.

Authors:  T Hökfelt; J Fahrenkrug; K Tatemoto; V Mutt; S Werner; A L Hulting; L Terenius; K J Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Inhibition by cholinergic agonists of the prolactin release induced by morphine.

Authors:  T Muraki; Y Tokunaga; T Nakadate; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.